[{"address1": "#21-1344 Summer Street", "city": "Halifax", "state": "NS", "zip": "B3H 0A8", "country": "Canada", "phone": "902 442 4655", "website": "https://appilitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Donald D. Cilla Jr., M.B.A., Pharmd", "title": "CEO, President & Director", "fiscalYear": 2024, "totalPay": 437650, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth G. Howling", "title": "Chief Financial Officer", "fiscalYear": 2024, "totalPay": 358344, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary S. Nabors Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "totalPay": 401525, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl  Gelhaus Ph.D.", "title": "Director of Non-Clinical Research", "fiscalYear": 2024, "totalPay": 220579, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arthur  Baran", "title": "Director of New Product Development", "fiscalYear": 2024, "totalPay": 229535, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "open": 0.0256, "dayLow": 0.0256, "dayHigh": 0.0256, "regularMarketOpen": 0.0256, "regularMarketDayLow": 0.0256, "regularMarketDayHigh": 0.0256, "forwardPE": -0.5, "volume": 47000, "regularMarketVolume": 47000, "averageVolume": 112314, "averageVolume10days": 58420, "averageDailyVolume10Day": 58420, "bid": 0.0195, "ask": 0.0279, "marketCap": 3031650, "fiftyTwoWeekLow": 0.014, "fiftyTwoWeekHigh": 0.05, "fiftyDayAverage": 0.02442, "twoHundredDayAverage": 0.025985, "trailingAnnualDividendYield": "NaN", "currency": "USD", "sharesOutstanding": 121266000, "heldPercentInsiders": 0.00062, "heldPercentInstitutions": 0.11841, "impliedSharesOutstanding": 130525000, "bookValue": -0.09, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1727654400, "trailingEps": -0.02, "forwardEps": -0.05, "52WeekChange": -0.13793105, "SandP52WeekChange": 0.31754446, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "APLIF", "underlyingSymbol": "APLIF", "shortName": "Appili Therapeutics Inc.", "longName": "Appili Therapeutics Inc.", "firstTradeDateEpochUtc": 1610116200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "df37bddd-c23d-386d-a253-a2f33cea7c20", "messageBoardId": "finmb_330222442", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.025, "recommendationKey": "none", "revenuePerShare": 0.007, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]